CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs

The CRIMALDDI Consortium has been a three-year project funded by the EU Framework Seven Programme. It aimed to develop a prioritized set of recommendations to speed up anti-malarial drug discovery research and contribute to the setting of the global research agenda. It has attempted to align thinkin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Steve A, Boulton, Ian C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830512/
https://www.ncbi.nlm.nih.gov/pubmed/24191947
http://dx.doi.org/10.1186/1475-2875-12-395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830512/
https://www.ncbi.nlm.nih.gov/pubmed/24191947
http://dx.doi.org/10.1186/1475-2875-12-395

Ejemplares similares